592 related articles for article (PubMed ID: 27534999)
1. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
[TBL] [Abstract][Full Text] [Related]
2. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.
Ringen PA; Melle I; Berg AO; Agartz I; Spigset O; Simonsen C; Sundet K; Andreassen OA
Schizophr Res; 2013 Jan; 143(1):84-9. PubMed ID: 23178107
[TBL] [Abstract][Full Text] [Related]
3. Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119).
Helle S; Ringen PA; Melle I; Larsen TK; Gjestad R; Johnsen E; Lagerberg TV; Andreassen OA; Kroken RA; Joa I; Ten Velden Hegelstad W; Løberg EM
Schizophr Res; 2016 Jan; 170(1):217-21. PubMed ID: 26682958
[TBL] [Abstract][Full Text] [Related]
4. No additive effect of cannabis on cognition in schizophrenia.
Power BD; Dragovic M; Badcock JC; Morgan VA; Castle D; Jablensky A; Stefanis NC
Schizophr Res; 2015 Oct; 168(1-2):245-51. PubMed ID: 26235754
[TBL] [Abstract][Full Text] [Related]
5. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
van der Meer FJ; Velthorst E;
Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
[TBL] [Abstract][Full Text] [Related]
6. Cannabis use related to early psychotic onset: Role of premorbid function.
Frascarelli M; Quartini A; Tomassini L; Russo P; Zullo D; Manuali G; De Filippis S; Bersani G
Neurosci Lett; 2016 Oct; 633():55-61. PubMed ID: 27637389
[TBL] [Abstract][Full Text] [Related]
7. Does accumulating exposure to illicit drugs bring forward the age at onset in schizophrenia?
Power BD; Dragovic M; Jablensky A; Stefanis NC
Aust N Z J Psychiatry; 2013 Jan; 47(1):51-8. PubMed ID: 23042939
[TBL] [Abstract][Full Text] [Related]
8. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.
Babatope T; Chotalia J; Elkhatib R; Mohite S; Shah J; Goddu S; Patel RA; Aimienwanu OR; Patel D; Makanjuola T; Okusaga OO
Psychiatr Q; 2016 Dec; 87(4):729-737. PubMed ID: 26875104
[TBL] [Abstract][Full Text] [Related]
9. Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosis.
Compton MT; Broussard B; Ramsay CE; Stewart T
Schizophr Res; 2011 Mar; 126(1-3):71-6. PubMed ID: 21036542
[TBL] [Abstract][Full Text] [Related]
10. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
[TBL] [Abstract][Full Text] [Related]
11. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
[TBL] [Abstract][Full Text] [Related]
12. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
[TBL] [Abstract][Full Text] [Related]
13. Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis.
Pauselli L; Birnbaum ML; Vázquez Jaime BP; Paolini E; Kelley ME; Broussard B; Compton MT
Schizophr Res; 2018 Jul; 197():544-549. PubMed ID: 29397281
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics influencing age at onset in psychotic disorders.
Ongür D; Lin L; Cohen BM
Compr Psychiatry; 2009; 50(1):13-9. PubMed ID: 19059508
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Changes in Cannabis Exposure on Psychotic Symptoms in Patients With Comorbid Cannabis Use Disorder.
Toftdahl NG; Nordentoft M; Hjorthøj C
J Dual Diagn; 2016; 12(2):129-36. PubMed ID: 27070732
[TBL] [Abstract][Full Text] [Related]
16. Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.
Kelley ME; Wan CR; Broussard B; Crisafio A; Cristofaro S; Johnson S; Reed TA; Amar P; Kaslow NJ; Walker EF; Compton MT
Schizophr Res; 2016 Mar; 171(1-3):62-7. PubMed ID: 26785806
[TBL] [Abstract][Full Text] [Related]
17. Premorbid adjustment in schizophrenia and schizoaffective disorder.
Saracco-Alvarez R; Rodríguez-Verdugo S; García-Anaya M; Fresán A
Psychiatry Res; 2009 Feb; 165(3):234-40. PubMed ID: 19162333
[TBL] [Abstract][Full Text] [Related]
18. Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender.
Dekker N; Meijer J; Koeter M; van den Brink W; van Beveren N; Kahn RS; Linszen DH; van Os J; Wiersma D; Bruggeman R; Cahn W; de Haan L; Krabbendam L; Myin-Germeys I;
Psychol Med; 2012 Sep; 42(9):1903-11. PubMed ID: 22452790
[TBL] [Abstract][Full Text] [Related]
19. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
[TBL] [Abstract][Full Text] [Related]
20. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
